Foghorn Therapeutics Inc.

NASDAQ: FHTX · Real-Time Price · USD
5.02
-0.13 (-2.43%)
At close: Aug 15, 2025, 3:59 PM
5.07
1.00%
After-hours: Aug 15, 2025, 05:10 PM EDT

Foghorn Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
55.45M 80.34M 345.8M 101.14M
Short-Term Investments
188.29M 153.72M 293.58M 53.15M
Long-Term Investments
n/a n/a 1.71M 1.73M
Other Long-Term Assets
1.78M 2.82M 7.98M 2.4M
Receivables
n/a n/a n/a 300M
Inventory
n/a n/a n/a n/a
Other Current Assets
5.85M 6.12M 5.6M n/a
Total Current Assets
249.6M 240.18M 345.8M 459.56M
Property-Plant & Equipment
32.6M 42.91M 49.4M 56.08M
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
34.38M 45.73M 59.09M 60.21M
Total Assets
283.98M 285.92M 404.88M 519.77M
Account Payables
3.79M 6.26M 5.41M 3.82M
Deferred Revenue
45.61M 34.55M 336.82M 28.32M
Short-Term Debt
9.07M 8.52M 5.97M 6.99M
Other Current Liabilities
-4.32M 4.09M 288K -1.01M
Total Current Liabilities
66.99M 58.44M 336.82M 48.69M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a 29K 143K
Total Long-Term Liabilities
262.52M 304.67M 67.95M 374.21M
Total Liabilities
329.51M 363.11M 404.77M 422.9M
Total Debt
37.13M 45.07M 51.51M 58.33M
Common Stock
6K 4K 4K 4K
Retained Earnings
-558.18M -471.56M -373.14M -264.26M
Comprehensive Income
135K -826K -3.99M -10K
Shareholders Equity
-45.53M -77.19M 112K 96.87M
Total Investments
188.29M 153.72M 293.58M 53.15M